Logo image of MGTA

MAGENTA THERAPEUTICS INC (MGTA) Stock Analyst Ratings

USA - NASDAQ:MGTA - US55910K1088 - Common Stock

0.6996 USD
-0.06 (-7.74%)
Last: 9/11/2023, 8:06:21 PM
Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to MGTA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 1.02. This target is 45.8% above the current price.
MGTA was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about MGTA.
In the previous month the buy percentage consensus was at a similar level.
MGTA was analyzed by 6 analysts. More opinions would make the average more meaningful.
MGTA Historical Analyst RatingsMGTA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -61 -55 -49 -43 -37 -31 -25 -19 -13 -7 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 0.701.011.021.021.05 - 44.37% 45.80% 45.80% 50.09%
MGTA Current Analyst RatingMGTA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2023-02-28 HC Wainwright & Co. Initiate Neutral
2023-01-26 BTIG Downgrade Buy -> Neutral
2023-01-26 Cowen & Co. Downgrade Outperform -> Market Perform
2023-01-26 Wedbush Downgrade Outperform -> Neutral
2022-12-21 BTIG Maintains Buy
2022-08-25 Goldman Sachs Downgrade Buy -> Neutral
2022-05-24 Goldman Sachs Maintains Buy
2022-04-18 Mizuho Maintains Buy
2022-04-18 BTIG Maintains Buy
2022-01-24 B. Riley Securities Maintains Buy
2022-01-06 Goldman Sachs Upgrade Neutral -> Buy
2021-08-03 JP Morgan Downgrade Overweight -> Neutral
2021-06-29 Cantor Fitzgerald Initiate Overweight
2021-06-15 BTIG Initiate Buy
2021-05-18 B. Riley Securities Initiate Buy

MAGENTA THERAPEUTICS INC / MGTA FAQ

What do analysts expect the price target to be for MAGENTA THERAPEUTICS INC (MGTA)?

6 analysts have analysed MGTA and the average price target is 1.02 USD. This implies a price increase of 45.8% is expected in the next year compared to the current price of 0.6996.


What is the consensus rating for MAGENTA THERAPEUTICS INC (MGTA) stock?

The consensus rating for MAGENTA THERAPEUTICS INC (MGTA) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.


How many analysts have analysed MAGENTA THERAPEUTICS INC (MGTA)?

The number of analysts covering MAGENTA THERAPEUTICS INC (MGTA) is 6.